1.13
price up icon3.67%   0.04
after-market アフターアワーズ: 1.08 -0.05 -4.42%
loading

I Mab Adr (IMAB) 最新ニュース

pulisher
Oct 28, 2024

I-Mab ADR (NASDAQ: IMAB) Stock: Investors Need To Know This - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Would I Buy Spectral AI Inc (NASDAQ: MDAI) Stock At Any Time In The Future? - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

If You Don’t Buy Hub Cyber Security Ltd (NASDAQ: HUBC) Now, You’ll Kick Yourself Later - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Itau Unibanco Holding S.A. ADR (NYSE: ITUB) Still Pointing Upwards - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Is Veritone Inc’s (NASDAQ:VERI) Stock On The Decline? - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Cisco Systems, Inc. (NASDAQ: CSCO): What’s Next After The Stock Plunge? - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Should This Give Tandem Diabetes Care Inc (NASDAQ: TNDM) Investors Sleepless Nights? - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Kinross Gold Corp. (NYSE: KGC) Investors Should Be Worried About This. - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Where Do Analysts See Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Heading? - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Not A Good News For Keycorp (NYSE: KEY): The Stock Could Go Down -34.98 Percent More - Stocks Register

Oct 28, 2024
pulisher
Oct 28, 2024

Analyst Forecast For Grab Holdings Limited (NASDAQ: GRAB) - Stocks Register

Oct 28, 2024
pulisher
Oct 24, 2024

Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading - MSN

Oct 24, 2024
pulisher
Oct 09, 2024

IMab (IMAB) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

IMAB’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Oct 08, 2024
pulisher
Oct 03, 2024

Company’s Banking Shares: Up -42.43% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle

Oct 03, 2024
pulisher
Sep 26, 2024

It makes sense and dollars to buy I-Mab ADR (IMAB) stock - SETE News

Sep 26, 2024
pulisher
Sep 26, 2024

Ratio Revelations: I-Mab ADR (IMAB)’s Financial Metrics in the Spotlight - The Dwinnex

Sep 26, 2024
pulisher
Sep 25, 2024

I-Mab ADR (IMAB) Stock: From Low to High in 52 Weeks - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

IMAB’s price-to-sales ratio: A comparative analysis with its peers - US Post News

Sep 25, 2024
pulisher
Sep 17, 2024

Piper Sandler maintains Overweight rating on I-Mab stock on drug data - Investing.com

Sep 17, 2024
pulisher
Sep 10, 2024

I-Mab reveals Phase 1 data for lung cancer treatment - Investing.com

Sep 10, 2024
pulisher
Sep 05, 2024

Federal Hill Taphouse & Kitchen abruptly closes - WPRI.com

Sep 05, 2024
pulisher
Sep 02, 2024

I-Mab ADR (IMAB)’s stock price in review: A technical analysis - US Post News

Sep 02, 2024
pulisher
Sep 02, 2024

There is no doubt that I-Mab ADR (IMAB) ticks all the boxes. - SETE News

Sep 02, 2024
pulisher
Aug 29, 2024

Earnings call: I-MAB Biopharma discusses pipeline progress and financials - Investing.com India

Aug 29, 2024
pulisher
Aug 28, 2024

I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates - PR Newswire

Aug 28, 2024
pulisher
Jul 16, 2024

Insight venture partners executives sell over $61 million in nCino shares By Investing.com - Investing.com India

Jul 16, 2024
pulisher
Jul 16, 2024

I-Mab appoints new chairman and interim CEO - Investing.com

Jul 16, 2024
pulisher
Jul 15, 2024

2024-07-15 | I-Mab Announces Leadership Transitions | NDAQ:IMAB | Press Release - Stockhouse Publishing

Jul 15, 2024
pulisher
Jul 04, 2024

Financial Health Report: I-Mab ADR (IMAB)'s Ratios Tell a Tale – DWinneX - The Dwinnex

Jul 04, 2024
pulisher
Jun 21, 2024

Teva Acquires Rights to Oncology Biosimilar Candidates - Yahoo News UK

Jun 21, 2024
pulisher
Jun 19, 2024

It is Poised to be a Bull Market for I-Mab ADR (IMAB) – Sete News - SETE News

Jun 19, 2024
pulisher
Jun 06, 2024

I-Mab names new Chief Medical Officer to enhance oncology pipeline - Investing.com India

Jun 06, 2024
pulisher
Jun 06, 2024

I-Mab names new Chief Medical Officer to enhance oncology pipeline By Investing.com - Investing.com

Jun 06, 2024
pulisher
Jun 06, 2024

I-Mab announces clinical trial collaboration with Bristol Myers - TipRanks

Jun 06, 2024
pulisher
Jun 05, 2024

Analysts review I-Mab ADR's rating – Knox Daily - Knox Daily

Jun 05, 2024
pulisher
Jun 05, 2024

I-Mab and Bristol Myers team up for cancer drug trial By Investing.com - Investing.com

Jun 05, 2024
pulisher
Jun 05, 2024

Watch this stock's price performance: I-Mab ADR (NASDAQ:IMAB) – US Post News - US Post News

Jun 05, 2024
pulisher
Jun 05, 2024

I-Mab ADR Inc. (IMAB) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Jun 05, 2024
pulisher
Jun 02, 2024

AbbVie (ABBV) Signs New Cancer/Immunology Deal With Frontier - Yahoo Lifestyle UK

Jun 02, 2024
pulisher
May 27, 2024

Check out these key findings about I-Mab ADR (IMAB) – Sete News - SETE News

May 27, 2024
pulisher
May 23, 2024

I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024 - GlobeNewswire Inc.

May 23, 2024
pulisher
May 19, 2024

AbbVie Partners With Chinese Biotech for Cancer Candidate - Yahoo News NZ

May 19, 2024
pulisher
May 07, 2024

(IMAB)Analyzing I-MAB's Short Interest By Benzinga - Investing.com UK

May 07, 2024
pulisher
May 02, 2024

Here's Why IMab Sponsored ADR (IMAB) is Poised for a Turnaround After Losing 26.8% in 4 Weeks - Yahoo Lifestyle UK

May 02, 2024
pulisher
May 01, 2024

Patent Law Changes Pose Threat to I-Mab Adr's Drug Candidate ProtectionTipRanks.com - TipRanks

May 01, 2024
pulisher
Apr 15, 2024

I-Mab Announces CMO Transition, Interim Successor NamedTipRanks.com - TipRanks

Apr 15, 2024
pulisher
Apr 02, 2024

I-Mab Finalizes Divestiture and Resolves ObligationsTipRanks.com - TipRanks

Apr 02, 2024
pulisher
Mar 18, 2024

Piper Sandler cuts I-Mab stock target to $10, keeps overweight rating - Investing.com

Mar 18, 2024
pulisher
Mar 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 12, 2024
pulisher
Sep 09, 2023

Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis - Nature.com

Sep 09, 2023
pulisher
Mar 31, 2023

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 - PR Newswire

Mar 31, 2023
pulisher
Jan 16, 2023

Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis - Nature.com

Jan 16, 2023
pulisher
Jan 06, 2023

Market Brief: Will the December CPI Report Help Further Tame Inflation Fears? - Morningstar

Jan 06, 2023
pulisher
Jan 03, 2023

Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar

Jan 03, 2023
pulisher
Dec 23, 2022

The Cheapest Stock in the World - Morningstar.ca

Dec 23, 2022
pulisher
Dec 19, 2022

10 of the Cheapest Stocks of 2022 - Morningstar

Dec 19, 2022
pulisher
Nov 16, 2022

Why Are Some China Healthcare Stocks Up 50%? - hk.morningstar.com

Nov 16, 2022
pulisher
Oct 19, 2022

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Oct 19, 2022
pulisher
Oct 13, 2022

Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage - Nature.com

Oct 13, 2022
pulisher
Oct 03, 2022

The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar

Oct 03, 2022
pulisher
Sep 27, 2022

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket By Benzinga - Investing.com UK

Sep 27, 2022
pulisher
Aug 18, 2022

I-Mab (IMAB) Down After Partner AbbVie Revises Partnership Deal - Yahoo New Zealand News

Aug 18, 2022
pulisher
Aug 12, 2022

AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody ... - ScienceDirect.com

Aug 12, 2022
pulisher
Jul 15, 2022

Markets Brief: Are We Headed for an Earnings Recession? - Morningstar

Jul 15, 2022
pulisher
Jun 17, 2022

Markets Brief: How High Can Mortgage Rates Go? - Morningstar

Jun 17, 2022
pulisher
May 20, 2022

New 5-Star Stocks - Morningstar

May 20, 2022
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):